Pediatric facial burns

Theodore A Kung1, Arun K Gosain

  • 1Department of Plastic Surgery, Rainbow Babies and Children's Hospital, Case Medical Center, Cleveland, Ohio 44106, USA.

Insights

Pediatric facial burns present unique challenges, impacting a child's growth, identity, and requiring specialized, long-term multidisciplinary care for optimal functional and psychosocial outcomes.

Area of Science:

  • Pediatric Surgery
  • Burn Management
  • Reconstructive Surgery

Background:

  • Burn injuries remain a significant cause of death and disability in children.
  • Facial burns are particularly devastating, leading to physical and psychosocial complications.
  • Pediatric facial burn management requires specific considerations distinct from adult protocols.

Purpose of the Study:

  • To highlight the unique challenges in managing pediatric facial burns.
  • To emphasize the critical differences between adult and pediatric burn care.
  • To outline the importance of a multidisciplinary approach for optimal outcomes.

Main Methods:

  • Review of current pediatric burn management principles.
  • Discussion of potential complications like growth alteration, amblyopia, and microstomia.
  • Exploration of surgical reconstruction techniques including skin grafts, flaps, and tissue expansion.

Main Results:

  • Facial burn scar contractures can impede facial growth and deform structures like the nose and teeth.
  • Early intervention is crucial for complications such as occlusion amblyopia and microstomia.
  • Psychosocial impact on a child's identity and self-concept is a critical consideration.

Conclusions:

  • Pediatric facial burns necessitate specialized surgical planning and reconstruction respecting facial aesthetic units.
  • Long-term, multidisciplinary care is essential for optimizing functional, cosmetic, and psychosocial recovery.
  • Addressing the unique physical and psychological needs of children with facial burns is paramount.

Related Concept Videos

Burn Injuries01:22

Burn Injuries

Burn injuries occur when the skin and underlying tissues are damaged due to exposure to heat, electricity, chemicals, radiation, or friction. They can vary in severity, from minor superficial burns to severe deep burns that can be life-threatening.
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...